Are cardiac patients at risk of nephropathy?

Cardiology, Nephrology

In this video, Dr. Suman Kirti, Endocrinologist, Holy Family Hospital, New Delhi, will discuss that if patients at risk of cardiovascular disease or nephropathy, then what is the other substitute for ACE inhibitors or ARBs. In such patients, treatment with calcium channel blockers (CCB) are given. Nowadays, calcium channel blockers are more advanced and the drugs act centrally thus reducing the central blood pressure. Dr. Suman will describe the advantage of reducing the central blood pressure. Hence CCB are preferred when ACE inhibitors and ARBs cannot be used as it improves the renal blood flow as well cardiac blood flow. Dr. Suman will also talk about different CCBs which are used in renal failure.

Dr. Suman Kirti

Dr. Suman Kirti is a Endocrinologist at Holy Family Hospital, New Delhi

More FAQs by Dr. Suman Kirti

What is metabolic memory?

What is glycated hemoglobin or (A1C) goals in patients with diabetes?

What is the equation between HBa1c and blood sugar?

Please login to comment on this article

Related FAQs

Subscribe To Our Newsletter

Filter out the noise and nurture your inbox with health and wellness advice that's inclusive and rooted in medical expertise.

Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks

Quick Links

Useful Links

Medbytes FAQ

About Us

Medtalks TV

Webinars

CMEs

Terms And Conditions

Conferences

Diabetes Prime

Are cardiac patients at risk of nephropathy?